Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-01-04 Sale |
2023-01-06 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
60 | $28.54 | $1,712 | 11,883 (Direct) |
View |
2023-01-04 Sale |
2023-01-06 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
73 | $28.53 | $2,083 | 18,536 (Direct) |
View |
2023-01-04 Sale |
2023-01-06 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
62 | $28.54 | $1,769 | 14,836 (Indirect Direct) |
View |
2023-01-04 Sale |
2023-01-06 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
198 | $28.54 | $5,651 | 45,966 (Direct) |
View |
2022-10-26 Sale |
2022-10-28 4:15 pm |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS |
194 | $6.52 | $1,265 | 2,030 (Direct) |
View |
2022-10-26 Sale |
2022-10-28 4:15 pm |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
214 | $6.51 | $1,393 | 2,098 (Indirect Direct) |
View |
2022-10-26 Sale |
2022-10-28 4:15 pm |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
194 | $6.51 | $1,263 | 2,418 (Direct) |
View |
2022-10-26 Sale |
2022-10-28 4:15 pm |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
261 | $6.51 | $1,699 | 5,809 (Direct) |
View |
2022-10-26 Sale |
2022-10-28 4:15 pm |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
561 | $6.52 | $3,658 | 4,464 (Direct) |
View |
2022-06-27 Sale |
2022-06-29 8:12 pm |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS |
2,613 | $0.37 | $967 | 111,203 (Direct) |
View |
2022-06-27 Sale |
2022-06-29 8:12 pm |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
2,613 | $0.37 | $967 | 130,595 (Direct) |
View |
2022-06-27 Sale |
2022-06-29 8:11 pm |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
3,144 | $0.37 | $1,163 | 285,201 (Direct) |
View |
2022-06-27 Sale |
2022-06-29 8:10 pm |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
3,092 | $0.37 | $1,144 | 115,541 (Indirect Direct) |
View |
2022-06-27 Sale |
2022-06-29 8:09 pm |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
7,975 | $0.37 | $2,951 | 251,183 (Direct) |
View |
2022-05-26 Sale |
2022-05-26 5:09 pm |
Kala Pharmaceuticals Inc. | KALA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
1,005,686 | $0.3636 | $365,667 | 7,039,613 (Indirect) |
View |
2022-05-23 Sale |
2022-05-25 5:17 pm |
Kala Pharmaceuticals Inc. | KALA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
2,829,314 | $0.52622 | $1,488,844 | 8,045,299 (Indirect) |
View |
2022-01-04 Sale |
2022-01-05 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
2,850 | $1.3 | $3,705 | 286,208 (Direct) |
View |
2022-01-04 Sale |
2022-01-05 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
3,504 | $1.3 | $4,555 | 526,345 (Direct) |
View |
2022-01-04 Sale |
2022-01-05 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
3,454 | $1.3 | $4,490 | 356,633 (Indirect Direct) |
View |
2022-01-04 Sale |
2022-01-05 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
9,518 | $1.3 | $12,373 | 1,034,158 (Direct) |
View |
2022-01-04 Sale |
2022-01-05 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS |
2,850 | $1.3 | $3,705 | 266,816 (Direct) |
View |
2021-10-26 Sale |
2021-10-28 8:06 pm |
Kala Pharmaceuticals Inc. | KALA | Chen Hongming CHIEF SCIENTIFIC OFFICER |
30,500 | $1.8138 | $55,321 | 204,515 (Direct) |
View |
2021-10-26 Sale |
2021-10-28 8:05 pm |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS |
9,449 | $1.8 | $17,008 | 116,666 (Direct) |
View |
2021-10-26 Sale |
2021-10-28 8:04 pm |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
9,449 | $1.8 | $17,008 | 136,058 (Direct) |
View |
2021-10-26 Sale |
2021-10-28 8:03 pm |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd CHIEF OPERATING OFFICER |
12,544 | $1.8 | $22,579 | 122,087 (Indirect Direct) |
View |
2021-10-26 Sale |
2021-10-28 8:02 pm |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K CHIEF MEDICAL OFFICER |
12,757 | $1.8 | $22,963 | 291,849 (Direct) |
View |
2021-10-26 Sale |
2021-10-28 8:01 pm |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
27,598 | $1.8 | $49,676 | 268,676 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-01-04 Option Award |
2023-01-06 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
9,525 | $0 | 11,883 (Direct) |
View |
2023-01-04 Option Award |
2023-01-06 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
12,800 | $0 | 18,536 (Direct) |
View |
2023-01-04 Option Award |
2023-01-06 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
12,800 | $0 | 14,836 (Direct) |
View |
2023-01-04 Option Award |
2023-01-06 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
41,700 | $0 | 45,966 (Direct) |
View |
2022-10-31 Option Award |
2022-11-01 4:12 pm |
N/A 2032-10-30 |
Kala Pharmaceuticals Inc. | KALA | Farid Marjan Director |
1,600 | $0 | 1,600 (Direct) |
View |
2022-06-16 Option Award |
2022-06-17 4:46 pm |
N/A 2032-06-15 |
Kala Pharmaceuticals Inc. | KALA | Myers C. Daniel Director |
40,000 | $0 | 40,000 (Direct) |
View |
2022-06-16 Option Award |
2022-06-17 4:45 pm |
N/A 2032-06-15 |
Kala Pharmaceuticals Inc. | KALA | Rosen Howard B Director |
40,000 | $0 | 40,000 (Direct) |
View |
2022-06-16 Option Award |
2022-06-17 4:45 pm |
N/A 2032-06-15 |
Kala Pharmaceuticals Inc. | KALA | Blumenkranz Mark S. Director |
40,000 | $0 | 40,000 (Direct) |
View |
2022-06-16 Option Award |
2022-06-17 4:45 pm |
N/A 2032-06-15 |
Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director |
40,000 | $0 | 40,000 (Direct) |
View |
2022-06-16 Option Award |
2022-06-17 4:45 pm |
N/A 2032-06-15 |
Kala Pharmaceuticals Inc. | KALA | Paull Robert Bradley Director |
40,000 | $0 | 40,000 (Direct) |
View |
2022-06-16 Option Award |
2022-06-17 4:45 pm |
N/A 2032-06-15 |
Kala Pharmaceuticals Inc. | KALA | KOVEN ANDREW I Director |
50,000 | $0 | 50,000 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Reumuth Mary CHIEF FINANCIAL OFFICER |
153,000 | $0 | 286,208 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Brazzell Romulus K SEE REMARKS |
238,000 | $0 | 526,345 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
238,000 | $0 | 356,633 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Iwicki Mark T CHIEF EXECUTIVE OFFICER |
775,000 | $0 | 1,034,158 (Direct) |
View |
2022-01-03 Option Award |
2022-01-05 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Trachtenberg Eric SEE REMARKS |
153,000 | $0 | 266,816 (Direct) |
View |
2021-11-15 Option Award |
2021-11-17 8:02 pm |
N/A 2031-11-14 |
Kala Pharmaceuticals Inc. | KALA | Kharabi Darius CHIEF BUSINESS OFFICER |
395,657 | $0 | 395,657 (Direct) |
View |
2021-11-15 Option Award |
2021-11-17 8:01 pm |
N/A 2031-11-14 |
Kala Pharmaceuticals Inc. | KALA | Blumenkranz Mark S. Director |
5,383,120 | $0 | 238,730 (Direct) |
View |
2021-10-15 Option Award |
2021-10-19 4:08 pm |
N/A 2031-10-14 |
Kala Pharmaceuticals Inc. | KALA | Myers C. Daniel Director |
42,000 | $0 | 42,000 (Direct) |
View |